AHL Partners’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
AHL Partners's CELG Position: Q4 2017 in Review
AHL Partners reduced its Celgene Corp (CELG) stake by 52% in Q4 2017, selling an estimated $2.51M and leaving 20,534 shares worth $2.14M. The position accounts for 0.03% of the portfolio, ranked #698.
AHL Partners first reported a position in CELG in Q4 2014 and has held it in 10 quarters since. The position peaked at $6.24M in Q3 2017. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.
- AHL Partners held 20,534 shares of Celgene Corp worth $2.14M as of Q4 2017.
- AHL Partners sold 22,221 Celgene Corp shares in Q4 2017, an estimated $2.51M.
- Celgene Corp made up 0.03% of AHL Partners's portfolio in Q4 2017, its #698 holding.
- AHL Partners first reported a position in Celgene Corp in Q4 2014 and has held it in 10 quarters since.
- AHL Partners's Celgene Corp position peaked at $6.24M in Q3 2017.
- 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.
Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.